886501-09-3 Usage
Uses
Used in Pharmaceutical Industry:
3-Chloro-2,4-difluorobenzyl alcohol is used as an intermediate in the production of various pharmaceutical products. Its unique structure allows it to be a key component in the synthesis of drugs with specific therapeutic properties.
Used in Agrochemical Industry:
In the agrochemical sector, 3-chloro-2,4-difluorobenzyl alcohol serves as an intermediate for the development of agrochemicals. Its incorporation into these products can contribute to enhanced crop protection and management solutions.
Used as a Reagent in Organic Synthesis:
3-Chloro-2,4-difluorobenzyl alcohol is utilized as a reagent in organic synthesis and chemical reactions. Its presence in these processes aids in the creation of a wide range of organic compounds for various applications.
Used in Research and Development:
Due to its high purity and stability, 3-chloro-2,4-difluorobenzyl alcohol is a valuable resource in research and development settings. It enables scientists and chemists to explore new chemical reactions and syntheses, potentially leading to the discovery of novel compounds and applications.
Check Digit Verification of cas no
The CAS Registry Mumber 886501-09-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,6,5,0 and 1 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 886501-09:
(8*8)+(7*8)+(6*6)+(5*5)+(4*0)+(3*1)+(2*0)+(1*9)=193
193 % 10 = 3
So 886501-09-3 is a valid CAS Registry Number.
InChI:InChI=1/C7H5ClF2O/c8-6-5(9)2-1-4(3-11)7(6)10/h1-2,11H,3H2
886501-09-3Relevant academic research and scientific papers
BETA-SECRETASE MODULATORS AND METHODS OF USE
-
Page/Page column 178-179, (2010/11/27)
The present invention comprises a new class of compounds useful for the modulation of Beta-secretase enzyme activity and for the treatment of Beta-secretase mediated diseases, including Alzheimer's disease (AD) and related conditions. In one embodiment, the compounds have a general Formula (I); wherein A, B, W, R3, R4, R5, i and j are defined herein. The invention also comprises pharmaceutical compositions including one or more compounds of Formula (I), methods of use for these compounds, including treatment of AD and related diseases, by administering the compound(s) of Formula (I), or compositions including them, to a subject. The invention also comprises further embodiments of Formulas (II) and (III), intermediates and processes useful for the preparation of compounds of the invention.
